富里 周太

Medicine & Life Sciences

1. Stuttering 100%
2. Small Cell Carcinoma 44%
3. TPF protocol 43%
4. Chemoradiotherapy 39%
5. Head and Neck Neoplasms 36%
6. Intratympanic Injection 29%
7. pegfilgrastim 29%
8. Relapsing Polychondritis 27%
9. Parapharyngeal Space 26%
10. Etoposide 26%
11. Broca Area 25%
12. Nasolacrimal Duct 25%
13. Transcranial Direct Current Stimulation 23%
14. Developmental Disabilities 22%
15. Febrile Neutropenia 22%
16. Cisplatin 21%
17. Sensorineural Hearing Loss 20%
18. Induced Pluripotent Stem Cells 20%
19. Sinusitis 20%
20. Carboplatin 20%
21. Docetaxel 20%
22. Cognitive Behavioral Therapy 18%
23. Anxiety 18%
24. Spinal Cord Injuries 17%
25. Fluorouracil 17%
26. Nutrition Assessment 17%
27. Paralysis 17%
28. Frontal Lobe 17%
29. Therapeutics 16%
30. Neoplasms 16%
31. Electrodes 15%
32. Brain 15%
33. Neoplasm Metastasis 15%
34. Schizophrenia 14%
35. Irinotecan 14%
36. Teratoma 13%
37. Steroids 13%
38. Psychiatry 13%
39. Cell Transplantation 13%
40. C-Reactive Protein 12%
41. Maxillary Sinus 10%
42. Survival 10%
43. Transplantation 9%
44. Recurrence 8%
45. Drug Therapy 8%
46. Tertiary Healthcare 8%
47. Remyelination 8%
48. Platelet Count 7%